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ABSTRACT
Background: Alzheimer’s disease (AD) is characterized by progressive neuronal loss in hippocamp. Epidermal 
neural crest stem cells (EPI-NCSC) can differentiate into neurons, astrocytes and oligodendrocytes. The purpose of 
this study was to evaluate the effects of transplanting EPI-NCSC into AD rat model. Methods: Two weeks after 
induction of AD by injection of Amyloid-β 1-40 into CA1 area of rat hippocamp, Y-maze and single-trial passive 
avoidance tests were used to show deficit of learning and memory abilities. EPI-NCSC were obtained from the 
vibrissa hair follicle of rat, cultured and labeled with bromodeoxyuridine. When Alzheimer was proved by 
behavioral tests, EPI-NCSC was transplanted into CA3 area of hippocamp in AD rat model. The staining of EPI-
NCSC markers (nestin and SOX10) was done in vitro. Double-labeling immunofluorescence was performed to 
study survival and differentiation of the grafted cells. Results: We showed that transplanted EPI-NCSC survive and 
produce many neurons and a few glial cells, presenting glial fibrillary acidic protein. Total number of granule cells 
in hippocamp was estimated to be more in the AD rat model with transplanted cells as compared to AD control 
group. We observed that rats with hippocampal damage made more errors than control rats on the Y-maze, when 
reward locations were reversed. Conclusion: Transplanted cells were migrated to all areas of hippocamp and the 
total number of granule cell in treatment group was equal compared to control group. Transplantation of EPI-NCSC
into hippocamp might differentiate into cholinergic neurons and could cure impairment of memory in AD rat 
model.  Iran. Biomed. J. 16 (1): 1-9, 2012
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INTRODUCTION
lzheimer’s disease (AD) is a progressive 
neurodegenerative disorder with characteristic 
clinical and pathological features, but with 
individual variations for age of onset and pattern of 
cognitive impairment [1]. No case of AD has been 
detected under the age of 20, but for people 85 years 
and older, the incidence is about 30% [2-4]. With each 
passing year, about four million people in the world 
develop dementia [2, 5]. Today, it affects nearly 30
million people in the whole world. As the average 
population increases, the number of AD patients is 
expected to rise exponentially and there will be 110
million AD patients in the world in 2050 [6]. The 
characteristic features of AD brains are formation of 
neurofibrillary tangles and the presence of amyloid
plaques. However, the neurotoxicity is believed to be 
responsible for the neuronal loss and the degeneration 
of the cholinergic system in AD patients [7, 8]. AD is 
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characterized by neuronal and synaptic loss throughout 
the brain, involving the basal forebrain cholinergic 
system, amygdala, hippocamp and several cortical 
areas [9-11]. Although AD massive neuronal loss 
occurs only in very few brain structures such as the 
hippocampal CA1 and CA2 regions, large parts of the 
brain, the entorhinal cortex and the locus coeruleus, are 
affected by pathological alterations and decreased 
neuronal metabolism [12]. Current treatments bring
only temporary symptomatic relief and do not halt the 
progression of this disease [13]. AD is also one of the 
candidate diseases for development of cell-replacement 
therapy, because transplantation of cells lacking the 
AD causing mutation can help to replace the lost 
neurons and reconstitute damaged neuronal 
connections [14].
Epidermal neural crest stem cells (EPI-NCSC) are 
multipotent remnants of embryonic NCSC in a 
postnatal location, the bulge of hair follicles. Sieber-
Blum et al. [15] described NCSC in the bulge region of 
adult murine whisker follicle and designated them as 
EPI-NCSC. The method of isolation was based on the 
emigration of cells from explanted bulge region. 
Emigrated cells expressed SOX10, a marker of neural 
nrest [16, 17], and intermediate filament protein nestin, 
a marker of immature and undifferentiated cells [18, 
19]. Nestin is also expressed in some cells in the bulge 
of hair follicle [20, 21]. EPI-NCSC were serially 
cultured under conditions that favored differentiation,
they showed a broad potential for generating cells 
which express markers appropriate for neurons, glias, 
smooth muscle cells, chondrocytes and melanocytes. 
EPI-NCSC responded to neuregulin-1 and BMP2 by 
generating Schwann cells and chondrocytes, 
respectively [15, 22].
In the present study, we tried to assess whether the 
EPI-NCSC grafted in the hippocamp of AD rat model
can differentiate to neurons or cholinergic neurons that 
impaired histology of the cholinergic system after
including a lesion in hippocamp. In addition, we 
focused on spontaneous alternation of AD rat model in 
Y-maze, which evaluates spatial working memory 
according to the previous reports.
MATERIALS AND METHODS 
Animals and housing conditions. All animal 
experiments were carried out according to the 
Guidelines of the Iranian Council for Use and Care of 
Animals and approved by the Animal Research Ethical 
Committee of Tehran University of Medical Sciences
(Tehran, Iran). Male Wistar rats (n = 40, 250-300 g of 
body weight) were purchased from the Animal Center 
of Iran Medical University (Tehran). All rats were 
maintained in a temperature-controlled environment of 
24 ± 1°C with a 12 h dark/light cycle (dark cycle: 8:00
P.M. to 8:00 A.M.) with free access to water and food.
The rats were randomly divided into four groups: A) 
Control group (intact); B) AD group (injected with 
Amyloid-β 1-40 [Aβ1-40] protein); C) Sham group 
(injected with deionized/distilled water instead of Aβ1-
40 protein) and D) EPI-NCSC-treated group (AD rats
receiving EPI-NCSC).
Alzheimer's disease rat model. Synthetic Aβ1-40
amyloid protein (Sigma-Aldrich, USA) was dissolved 
in deionized/distilled water at 2 nmol/µl, stored at -
70C and incubated at room temperature for 2 h before 
use. Rats were anesthetized with intraperitoneal 
injection of 10% ketamine (60 ml/kg) and 1% xylazine 
(20 mg/kg) (both from Alfasan, Woerden, Holland)
and mounted in a stereotaxic apparatus (Stoelting Co., 
USA) for localization of the hippocamp. An incision 
was made into the scalp and the cranium drilled 
through with a mini-drill to a depth of 2.6 mm. The 
point of CA1 region of hippocamp was localized at 2.0
mm lateral and -3.8 mm anterior to the posterior 
fontanel, followed by Paxinos and Watson atlas. In AD 
sham group, 4 µl of deionized/distilled water was 
injected bilaterally into each hippocamp using a 26-
gauge needle connected to a micro syringe (Hamilton) 
over a period of 12 min. The needle was slowly 
withdrawn after the injection.
Bulge explants and epidermal neural crest stem cell
culture. Bulge explants from whisker follicles of 7-10-
week-old Wistar rat were prepared, dissected, cleaned
and cut longitudinally and then transversely below and 
above the bulge region. The bulges were then rolled 
out of the capsule and placed into collagen-coated 
culture plates, where they adhered to the substratum 
within 24 h. Three to four days post-implantation, cells 
started to emigrate from the bulge explants onto the 
culture substratum. The culture medium was consisted 
of 3:1 supplemented mixture medium DMEM/F12
containing 5% fetal bovine serum, antibiotics (100
U/ml penicillin, 100 μg/ml streptomycin and 0.5 µg/ml 
fungizon), 10 ng/ml epidermal growth factor (Sigma-
Aldrich, USA), 10-9 M cholera toxin (Sigma-Aldrich,
USA), 0.5 mg/ml hydrocortisone and 5 μg/ml insulin. 
Three to four days post onset of emigration, bulges 
were removed and the adhering cells were detached by 
trypsin treatment and subsequently subcultured (Figs. 1
and 2) [23].
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Fig 1. Isolation and explanation of hair follicle bulge. (A) Whisker pad of rat. E, epidermis; D, dermis and F, follicle (×100); (B)
isolated hair follicle (×100); (C) dissected and cleaned hair follicle (×400) and (D) bulge of hair follicle rolled in capsule (×400). 
Arrows show the bulge.
Immunocytochemistry. Ten days after isolation and 
culture, cells passaged and plated on collagen-coated 
cover slips overnight, washed in PBS for 3 × 5 and 
fixed in 4% paraformaldehyde (PFA) for 10 min. 
Thefixed cells were washed in PBS for 3 × 5 and 
incubated in blocking buffer (10% goat serum, Sigma-
Aldrich, USA and 0.3% Triton X-100, Fluka, USA) at 
room temperature for 30 min. They were then 
incubated at 4°C overnight with the following primary 
antibodies: mouse anti-nestin monoclonal antibody  
(1:200, Millipore, USA), mouse anti-SOX10
monoclonal antibody (1:200, Sigma-Aldrich, USA), 
monoclonal anti β-III tubulin antibody (1:400, Sigma-
Aldrich, USA) and monoclonal anti-GFAP (glial 
fibrillary acidic protein) antibody (1:1000, Invitrogen,
USA). The next day, the cells were rinsed for 3 × 5
min to remove unbound primary antibodies.
Subsequently, they were incubated at room 
temperature for 2 h with the following secondary 
antibodies: goat anti-mouse FITC-conjugate IgG 
(1:200, Sigma-Aldrich, USA) and Alexa Fluor 546-
conjugated goat anti-mouse (1:400, Invitrogen, USA). 
Cell nuclei were counterstained in PBS with 1 μg/ml 
diamidino pheylindole dihydro-chloride Sigma-
Aldrich, USA) in the dark at room temperature for 1
min. After washing, the cover slips were removed from 
the 6 wells, mounted on a slide with mounting media 
and visualized using a 
fluorescence microscope. To examine the specificity of 
the nestin antibody, 3T3 fibroblast-like cells were used 
as negative control cells (Pasteur Institute of Iran,
Tehran). For morphological studies, labeled cells were 
identified using an Olympus photomicroscope 
(PROVIS AX70, Japan), equipped with a digital 
camera (DP11, Japan).
Bromodeoxyuridine (BrdU) labeling. BrdU, a 
thymidine analogue that is incorporated into the DNA 
of dividing cells during S phase, was used to label 
newly synthesized DNA. Forty eight to 72 h before cell 
transplantation, BrdU (5 µmol/ml; Sigma-Aldrich, St. 
Fig. 2. Characteristics of epidermal neural crest stem cell (EPI-NCSC) and phase contrast microscopy. (A) Explants 20 h after onset 
of EPI-NCSC emigration. Migratory cells are present on the collagen substratum; (B) colony formation; (C) proliferation and 
expanded EPI-NCSC and (D) EPI-NCSC were labeled with BrdU prior to transplantation. Arrow shows the bulge (scale bar = 200
µm).
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Louis, MO, USA) was added to flask of cultured cells. 
For checking cell labeling with BrdU, 48 h after cell 
labeling, the labeled cells that had been on collagen-
coated cover slips were washed in PBS for 3 × 5 min
and fixed in 4% PFA for 10 min. Then, the fixed 
cellswere washed in PBS for 3 × 5 min and incubated 
in 2N HCL at 60C for 45 min and washed 2 times in 
0.1 M borate buffer (pH 8.3). After washing in 
blocking buffer (10% goat serum, Sigma-Aldrich,
USA/0.3% Triton X-100 Fluka, USA and 1% BSA) at 
room temperature for 60 min, the incubated cells were 
again incubated with the primary antibody anti-BrdU 
(1:500, Sigma-Aldrich, USA) at 4°C overnight. The 
next day, the cells were rinsed in PBS for 3 × 5 min to 
remove unbound primary antibodies. Subsequently, 
they were incubated at room temperature for 1 h with 
secondary antibody: goat anti-mouse FITC conjugate 
IgG (1:200, Abcam, Cambridge, UK), washed in PBS 
for 3 × 10 min, mounted with mounting media and 
visualized using a fluorescence microscope. (Fig. 2D).
Transplantation of epidermal neural crest stem 
cells. Fourteen days after induction of AD model, Y-
maze and single-trial passive avoidance tests were 
carried out. Then, EPI-NCSC were injected bilaterally 
into rats hippocampus of EPI-NCSC-treated group (a 
total of 200-300,000 cells were injected into each 
hippocamp in a total of 4 µl solution containing 50-
60,000 cells per µl). The site of injection was CA3
region with depth of 3.8 mm, 2.6 mm lateral and -4.30
mm anterior to posterior fontanel, followed by Paxinos 
and Watson atlas. 
Behavioral measurements:
Y-maze task. Rats were examined in the behavioral 
assessment Y-maze test, initiated 14 day after Aβ 
injection and 4 weeks after cell delivery. All testing 
was carried out from 3 p.m. to 6 p.m. Behavioral 
testing was conducted in an enclosed Plexiglas Y-
maze. The Y-maze is a three-arm horizontal maze with 
40 cm long, 30 cm high and 15 cm wide in which the 
arms are symmetrically disposed at 120° angles from 
each other. The maze floor and walls were constructed 
from dark opaque polyvinyl plastic as described 
previously. Rats were initially placed within one arm, 
and the sequence and number of arm entries were 
recorded manually for each rat over an 8-min period. 
Alternation was defined as successive entries into the 
three arms on overlapping triplet sets. The alternation 
percentage was calculated as the ratio of actual to 
possible alternations (defined as the total number of 
arm entries minus two) ×100. The number of arm 
entries serves as an indicator of locomotors activity
[24]. 
Single-trial passive avoidance test: This test was 
performed 16 days post surgery and 4 weeks after cell 
delivery. 
Apparatus. The apparatus for the step-through 
passive inhibitory avoidance test (BPT Co., Tehran, 
Iran) consisted of an illuminated (base side, 20 × 20
cm; floor side, 13.5 × 10 cm and height 30 cm) and a 
dark (base side, 20 × 20 cm; floorside, 15.5 × 10 cm
and height 30 cm) compartments. These two 
compartments were divided by a wall that had either a 
guillotine door or hole (5-10 cm) that connected them. 
The dark compartment had a removable cover made of 
the same material. A lamp (20 W, positioned 20 cm 
above the apparatus) was used to illuminate the side of 
the light compartment.
Procedure. The test was conducted on 4 consecutive 
days. All rats were adapted to the apparatus on the first 
and second days of testing for 5 min. In the acquisition 
trial, the rats were gently placed into the illuminated 
compartment, facing away from the dark compartment. 
Then, the door to the dark compartment was opened 
and the rats were allowed to step into it with all four 
paws. On the third day, the rats individually entered the 
light compartment and remained there for 2 min then 
the guillotine door was opened and the rat entered the 
dark compartment and received a 2 s, 1 mA electric 
foot shock. To retest, 24 h later, each rat was again 
placed in the light compartment. The latency to step 
through the dark compartment (maximum 600 s) was 
measured and recorded as index for the passive 
avoidance behavior. The behavioral observations were 
carried out between 12:00 M.D. to 15:00 P.M. [25]. 
Histological procedure. Animals were anesthetized
with ketamine (100 mg/kg) and xylazine (20 mg/kg) 
mixture 4 weeks after cell transplantation and perfused 
transcardially with 0.9% saline, followed by 4% PFA. 
Brains were post-fixed in 4% PFA in phosphate buffer 
overnight. Then, the brains were removed and fixed in 
the similar solution for 24 h. Following routine 
processing in paraffin embedded, a total of 16 coronal 
brain sections (8 μm) were collected from each brain 
with a rotary microtome (Leitz, 1512, Germany). Every 
section was spaced by 5 sections to ensure that the 
examined sections were at a similar level between 
control and experimental rats. For cell count, neuron 
numbers were counted in all regions of molecular layer 
cells in the CA1 region of hippocamp on Nissl stained 
in the light microscope (magnification ×40). The 
results were expressed as density (number/mm2) and 
calculated as percentage of control rats. One of the five 
sections of each rat was subjected to modified 
Bielschowsky staining to determine amyloid plaques, 
neurofibrillary tangles and Nissl dye staining for cell 
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Fig. 3. Epidermal neural crest stem cell (EPI-NCSC) multipotency and self-renewing. (A) Expression of immature and 
undifferentiated cells marker, nestin; (B) expression of neural crest marker, SOX10. EPI-NCSC differentiated into neuron and glia in 
vitro; (C) expression of marker of glias (glial fibrillary acidic protein) and (D) expression of neuron-like marker (β-ІІІ tubulin). Nuclei 
were counterstained using diamidino pheylindole dihydrochloride (scale bar = 100 µm).
count. Some brain sections from all transplanted 
animals were stained by hematoxilin and eosin to 
assess possible tumor formation.
Immunohistochemistry. Paraffin sections were 
stained with Envision G12 double-stain system kit 
(DAKO, USA), according to the kit protocol. 
Following primary antibodies were used in this 
protocol: monoclonal anti β-III tubulin antibody 
(1:400, Sigma-Aldrich, USA), monoclonal anti-GFAP 
antibody (1:1000, Invitrogen, USA), monoclonal anti-
ChAT antibody (1:200, Sigma-Aldrich, USA) and 
monoclonal anti-BrdU antibody (1:500, Sigma-
Aldrich, USA). The secondary antibodies in this 
protocol were horse reddish peroxidase and alkaline
phosphatase that were detected by diaminobenzidine
(DAB) and permanent red staining.
Statistical analysis. Results were expressed as mean
± S.E.M. in the passive avoidance task and Y-maze 
task. Data were analyzed by one-way analysis of 
variance (ANOVA), followed by post hoc analysis, and 
Student’s t-test was used whereas it was appropriate. 
Differences were considered significant at the level of 
P<0.05.
RESULTS
Epidermal neural crest stem cell are self-renewing 
and multipotent. We first characterized the EPI-NCSC
used in this study in vitro to determine if they are 
capable of self-renewal and multipotent; giving rise to 
all neural lineages (neurons and glias). Immuno-
histochemical analysis of undifferentiated EPI-NCSC
revealed coexpression SOX10 and nestin, well-
established markers of these hair follicle stem cells
(Fig. 3). In contrast, adding mitogen and neuronal 
differentiation induces expression of neuronal and glial 
markers (Fig. 3). Therefore, the EPI-NCSC used 
represent multipotent, self-renewing stem cells.
Transplanted NSC rescue cognitive deficits. We 
determined cognition deficit in rats with well-
established plaque and tangle pathology and behavioral
deficits. In this study, short-term spatial memory was 
examined by Y-maze task. AD group showed a 
significant reduction in alternation behavior compared 
to control and sham groups (P<0.05, Fig. 4). There was 
no significant difference between sham and control 
groups. In passive avoidance test, the AD group rats 
indicated a significant damage in retention. The mean 
of acquisition in passive avoidance test showed a non-
significant decrease in sham group compared to control    
       
Fig. 4. Percent of alternation behavior in Y-maze task in 
studied groups (mean ± SEM). * shows P<0.05 in AD group as 
compared to sham, control and treatment groups.
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Fig. 5. Single-trial passive avoidance test. Step-through 
latency of control, sham and treatment groups compared to AD 
group, *P<0.05.
group. This result exhibited significantly decreased 
acquisition to passive avoidance response in AD group 
compared to control and sham groups (P<0.05, Fig. 5).
One month after EPI-NCSC delivery, rats were again 
habituated, trained, and tested on 2 hippocampal-
dependent behavioral tasks. As shown in Figures 4 and 
5, the learning and memory impairments rescued in 
treatment group and was significant compared to AD 
group.
However, there was no significant difference among 
sham, control and treatment groups. The mean of 
acquisition in passive avoidance test showed a non-
significant decrease in sham and treatment groups 
compared to control group. In addition, static
evaluation showed that the mean of animal entrance to 
arms in Y-maze test in four groups (sham group, 17.8; 
control group, 18.6; AD group, 17 and treatment 
group, 18) was not significant.
Histological procedure showed pathology 
characterization of Alzheimer and the cell replacement 
after   EPI-NCSC  delivery. In   this study,  amyloid 
plaques were detected in the cerebral cortex and
hippocamp by Bielschowsky silver staining. The sizes
of these plaques were smaller than 210 µm. Also, 
neurofibrillary tangles were seen in AD and 
transplantation groups, but not in other groups. 
Furthermore, Aβ pathology did not alter in the 
treatment group (Fig. 6D and 6E) and reductions in the 
neuronal populations were observed in hippocamp. 
Nissl-stained neuronal densities indicated that AD 
group had consistently reduced the neuron densities 
55.6% in the CA1. An increase in the number of 
neurons was observed after transplantation, though not 
up to its normal level (Fig. 6C). Furthermore, 
hematoxilin and eosin staining revealed that EPI-
NCSC did not form tumor, because there were not 
hypertrophic and dividing nuclei in all transplanted rats 
4 week after transplantation (Fig. 6A and 6B).
EPI-NCSC-induced cognitive improvement was 
accompanied not only with an increase in cell number 
but also with cell differentiation. The increase in cell 
number was showed by cell count in CA1 area in nissl 
staining (Table 1). Using double-staining procedure, 
many glial cells were detected in and around of 
transplanted site that present BrdU-GFAP; however, 
many cells were detected that present BrdU-ChAT and 
BrdU-βIII tubulin too. Using double-staining Envision 
kit (DAKO, USA), we showed that the nuclei of 
differentiated cells, that had presented BrdU, were 
brown and presentation of β-III tubulin or GFAP in 
cytoplasm was red. For detection of differentiated 
cholinergic cells, we used DAB staining for ChAT in 
cytoplasm and permanent red staining for BrdU in 
nuclei. Therefore, differentiated  cholinergic neurons
Fig. 6. Histology study of hippocamp and hematoxilin and eosin staining. (A) Control group and (B) treatment group did not show 
hypertrophic and dividing nuclei 4 week after cell transplantation (tumor formation) ( ×400). (C) Nissl staining for cell count in CA1
area (×400). (D) Bielschowsky staining, amyloid plaques (arrow 1) and neurofibrillary tangle (arrow 2) in CA1 area in the AD group 
and (E) no amyloid plaques and neurofibrillary tangle in control group (×1000).
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Fig. 7. Differentiation of epidermal neural crest stem cell (EPI-NCSC) after transplantation by using EnVision kit. (A) The cells 
incubated with bromodeoxyuridine (BrdU) 48 h before transplantation, then paraffin embedded sections immunostained with 
antibodies against BrdU (diaminobenzidine [DAB], brown) and glial fibrillary acidic protein (permanent red, red). (B) Neuron 
like, determined by their expression of β-ІІІ tubulin (permanent red, red), had incorporated BrdU (DAB, brown). (C) ChAT positive 
neuron (DAB, brown) had incorporated BrdU (Permanent red, red) as determined by double labeling with antibodies against ChAT
and BrdU (×400).
were detected by brownish cytoplasm and reddish 
nuclei. We did not count differentiated cells, because 
they were diffused not only in hippocamp but also in 
the other parts of brain (Fig. 7).
DISCUSSION
In this study, the experiments were performed on a 
recently developed AD rat model. Our findings 
indicated that AD rats have a decreased number of 
neurons in the CA1 zone. We also found amyloid
plaques and neurofibrillary tangles in the hippocamp, 
cortex and white matter. Using Y-maze and passive 
avoidance response tests, we demonstrated that AD 
group had significantly decreased behavior scores 
compared to control and sham groups. These results 
are in agreement with the other findings [14, 26-28]. 
Similar to other studies in this field, it is confirmed that 
deposition of Aβ in AD brains impairs learning and 
memory. In addition, the passive avoidance procedure 
is a quick and simple task to administer this procedure, 
and is widely used to measure cognitive alterations 
after drug administration, lesions, and behavioral 
manipulations [29]. The passive avoidance test has 
been widely used to evaluate the ability of rodent 
working memory in association with cortical and 
hippocampal functions [30]. In our previous study, the 
latency periods of passive avoidance response in rats 
were evaluated and the retention of memory was 
significantly disturbed in the AD groups [31]. In 
treatment group, memory was improved and there were 
no significant differences between them and sham and 
control groups.  
Our observations indicate that rat’s EPI-NCSC in 
hair follicles retain the capacity to differentiate into 
non-mesenchymal derivatives specifically neurons, 
suggesting that intrinsic genomic mechanisms of 
commitment, lineage restriction, and cell fate are 
mutable. Environmental signals apparently can elicit 
the expression of pluripotentiality that emphasizes on 
accepted fate restrictions of cells originating in neural 
crest-derived germ layers. These adult cells are self-
renewing and multipotential [21, 32-35], thereby 
fulfilling many of the criteria of a stem cell population. 
To our knowledge, this is the first report that EPI-
NCSC can differentiate into neurons in vivo. EPI-
NCSC may be useful in the treatment of a wide variety 
of neurologic diseases, offering significant advantages 
over other “stem” cells. The hair follicle stem cells 
(EPI-NCSC) are readily accessible, overcome the risks 
of obtaining neural stem cells from the brain, and 
provide a renewable population. Autologous 
transplantation overcomes the ethical and 
immunological concerns in comparative with the use of 
fetal tissue. Moreover, EPI-NCSC grows rapidly in 
culture, precluding the need for immortalization, and 
differentiates into neurons exclusively with use of a 
simple protocol that we and other used in previous 
studies [34, 36, 37]. Furthermore, these cells did not 
have the risk of tumor formation [37]. In this study, 
grafted cells did not form tumor. In the other studies, 
tumor formation after stem cell transplantation was 
evaluated at the same duration of time [27, 38].
In the present study, we have used dual-labeling 
immunohistochemistry to demonstrate changes in 
transplanted cell within the hippocampus of AD rat 
model. We showed that transplanted cells not only 
survived and migrated in the host tissue but also 
expressed neuron-like cells, cholinergic cells and 
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GFAP-positive cells. This shows that EPI-NCSC are 
very likely to differentiate into neuron-like and glial 
cells in vivo in AD model. It has been demonstrated 
that EPI-NCSC can differentiate into neurons and 
neuroglia in vitro and in vivo. Moreover, other studies 
have indicated that these cells can differentiate into 
Schwann cells that improved movement in peripheral 
nerve and spinal cord injury model [37, 39]. In the 
present study, we observed more neurons that did not 
present BrdU, showing that neurogenesis was 
happened. EPI-NCSC integrated with the brain tissue 
and their differentiation improved the microenviroment 
to induce host neural stem cell. Clearly, the brain 
microenvironment has a profound influence on the 
survival, migration, and differentiation of EPI-NCSC-
derived neurons. It will be interesting to characterize 
the factors that affect these parameters. This highlights 
the effect of brain on cells. An increase in the number 
of hippocampal neuron was seen in the AD rat model 
after cell delivery, though not up to its normal level 
and like the control group. Our finding is similar to 
other papers in this field [27, 28].
The beneficial effect of the grafted cells could be 
attributed to one or both of two functions of the cells in 
vivo: (i) simple secretion of acetylcholine from 
transplanted cells or (ii) actual functional integration 
into the host tissue [40]. We found cholinergic 
differentiation after transplantation of EPI-NCSC.
Some researchers have shown that generation of 
cholinergic neurons from other cells in experimental 
animals is possible [27, 41]. Hopefully a similar 
outcome will be demonstrated for human stem cells. 
Alternatively, stem cells derived from brain, blood, 
bone marrow, or skin may be convertible to cholinergic 
neurons. Immortalized cholinergic neurons may be 
useful if cell replication after transplant can be 
controlled. Further studies are required to determine 
whether newly differentiated neurons are functionally 
integrated into the injured hippocamp and to 
characterize the mechanisms underlying stem cell 
differentiation in the damaged central nervous system. 
Moreover, we tested the reference memory function 
of neuronal-transplanted animals. Strengthening of this 
kind of memory requires generation of new synapses 
between grafted cells and host neurons, in addition to 
secretion of acetylcholine. Therefore, we propose that 
transplanted cells contributed to the improvement of 
memory function by both making new synapses and 
acetylcholine secretion.
We have demonstrated that rat EPI-NCSC survives
and differentiates into neurons, especially cholinergic 
neurons for 4 weeks after grafting in the brain of an 
experimental rat AD and contributes to cognitive 
functional recovery. The improvement in reference 
memory function in grafted animals suggests that 
transplanted cells exert their effect by generating new 
synapses as well as acetylcholine secretion. The EPI-
NCSC display greatly diminished proliferative activity 
and do not result in obvious tumor formation in the 
long-term graft, suggesting their potential therapeutic 
application in Alzheimer's treatment.
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